These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7151293)

  • 1. [Feed-back control of blood glucose--present status and future of artificial endocrine pancreas].
    Shichiri M; Kawamori T
    Horumon To Rinsho; 1982 Sep; 30(9):953-7. PubMed ID: 7151293
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dawn phenomenon. Studies using artificial pancreas in insulin dependent diabetic patients].
    Rodríguez García MA; Gutiérrez López MA; Durán García S
    Med Clin (Barc); 1988 Jun; 91(3):81-2. PubMed ID: 3050312
    [No Abstract]   [Full Text] [Related]  

  • 3. The artificial pancreas: how close are we to closing the loop?
    Clarke WL; Kovatchev B
    Pediatr Endocrinol Rev; 2007 Jun; 4(4):314-6. PubMed ID: 17643078
    [No Abstract]   [Full Text] [Related]  

  • 4. Medicine. A pancreas in a box.
    Clery D
    Science; 2014 Jan; 343(6167):133-5. PubMed ID: 24408414
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of the blood glucose-controlled Biostator for intravenous infusion of insulin for optimal insulin therapy (so-called corrective feedback)].
    Sieradzki J; Szurkowska M
    Pol Arch Med Wewn; 1986 Feb; 75(2):127-34. PubMed ID: 3748830
    [No Abstract]   [Full Text] [Related]  

  • 6. Not the artificial beta cell algorithms but their parameter values are important in automated glucose control of insulin-dependent diabetes.
    Fischer U; Jutzi E; Albrecht G; Abel P; Salzsieder E; Freyse EJ; Detscheff W; Lemke K
    Trans Am Soc Artif Intern Organs; 1983; 29():488-91. PubMed ID: 6673274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic hyperinsulinism induced by the use of continuous insulin infusion pumps and the artificial pancreas in diabetic patients].
    Bergua M; Levy I; Casamitjana R; Figuerola D
    Med Clin (Barc); 1983 Sep; 81(6):243-5. PubMed ID: 6358714
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucose sensors and insulin infusion systems--current technical status and future aspects].
    Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1989; 95():725-36. PubMed ID: 2690538
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glucose-controlled insulin infusion systems (GCIIS, artificial pancreas) in therapy of diabetes mellitus and organic hyperinsulinism].
    Sailer D
    Verh Dtsch Ges Inn Med; 1987; 93():309-12. PubMed ID: 3442106
    [No Abstract]   [Full Text] [Related]  

  • 10. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus.
    Shichiri M; Kawamori R; Hakui N; Asakawa N; Yamasaki Y; Abe H
    Biomed Biochim Acta; 1984; 43(5):561-8. PubMed ID: 6477542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term application of wearable artificial endocrine pancreas--closed-loop intravenous vs subcutaneous insulin infusion.
    Shichiri M; Kawamori R; Goriya Y; Yamasaki Y; Nomura M; Asakawa N; Kubota M; Kamada T
    Life Support Syst; 1985; 3 Suppl 1():583-7. PubMed ID: 3916624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the "dawn phenomenon" using an artificial endocrine pancreas].
    Khristov V; Petkova M; Tsanev A
    Vutr Boles; 1988; 27(6):35-8. PubMed ID: 3247701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with using automated insulin infusion systems in diabetes mellitus type 1].
    Perelygina AA; Antsiferov MV; Starostina EG
    Sov Med; 1988; (5):72-5. PubMed ID: 3212534
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of diabetes mellitus with insulin infusions].
    Mirouze J; Selam JL; Rodier M; Lapinski H; Saeidi C; Richard JL
    Bull Acad Natl Med; 1984; 168(1-2):80-90. PubMed ID: 6383552
    [No Abstract]   [Full Text] [Related]  

  • 15. Biostator Glucose Controller: a building block of the future.
    Young A; Herf S
    Diabetes Educ; 1984; 10(2):11-2. PubMed ID: 6378557
    [No Abstract]   [Full Text] [Related]  

  • 16. [Continuous insulin infusion in diabetics treated with surgical implants].
    Kmoch J; Polácková H; Chaloupka F; Svoboda Z; Slezák Z; Chytil V
    Cas Lek Cesk; 1987 Nov; 126(46):1433-6. PubMed ID: 3319176
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of an artificial beta cell based on telemetry].
    Wilke W; Detschew W; Kasch J; Rebrin K; von Woedtke T; Abel P
    Biomed Tech (Berl); 1990; 35 Suppl 3():228-9. PubMed ID: 2078707
    [No Abstract]   [Full Text] [Related]  

  • 18. Modelling the glucose-insulin system as a basis for the artificial beta cell.
    Fischer U; Salzsieder E; Jutzi E; Albrecht G; Freyse EJ
    Biomed Biochim Acta; 1984; 43(5):597-605. PubMed ID: 6383364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of artificial endocrine pancreas (Biostator; GCIIS) performance combining feedback controlled insulin administration with a pre-programmed insulin infusion.
    Calabrese G; Bueti A; Zega G; Giombolini A; Bellomo G; Antonella MA; Massi-Benedetti M; Brunetti P
    Horm Metab Res; 1982 Oct; 14(10):505-7. PubMed ID: 6757081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.